[
    [
        {
            "time": "2021-02-16",
            "original_text": "Lilly's (LLY) Bamlanivimab Combo Lowers COVID-19 Hospitalization",
            "features": {
                "keywords": [
                    "Bamlanivimab",
                    "Combo",
                    "Lowers",
                    "COVID-19",
                    "Hospitalization"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Lilly's (LLY) Bamlanivimab Combo Lowers COVID-19 Hospitalization",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-02-17",
            "original_text": "Vir Will Test Its Covid-19 Antibody With Eli Lilly’s, Sending Shares Up Again",
            "features": {
                "keywords": [
                    "Vir",
                    "Test",
                    "Covid-19",
                    "Antibody",
                    "Eli Lilly",
                    "Shares",
                    "Up"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Vir Will Test Its Covid-19 Antibody With Eli Lilly’s, Sending Shares Up Again",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-02-18",
            "original_text": "The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement",
            "features": {
                "keywords": [
                    "Sorrento",
                    "Immutep",
                    "Surge",
                    "COVID-19",
                    "Study",
                    "Data",
                    "T2 Biosystems",
                    "Sinks",
                    "Preannouncement"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "mixed"
            },
            "scores": {
                "News_content": "The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-02-19",
            "original_text": "Lilly, Vir Biotechnology and GSK announce first patient dosed in expanded BLAZE-4 trial evaluating bamlanivimab (LY-CoV555) with VIR-7831 (GSK4182136) for COVID-19",
            "features": {
                "keywords": [
                    "Lilly",
                    "Vir Biotechnology",
                    "GSK",
                    "BLAZE-4",
                    "Trial",
                    "Bamlanivimab",
                    "VIR-7831",
                    "COVID-19"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Lilly, Vir Biotechnology and GSK announce first patient dosed in expanded BLAZE-4 trial evaluating bamlanivimab (LY-CoV555) with VIR-7831 (GSK4182136) for COVID-19",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-02-20",
            "original_text": "Eli Lilly’s Antibody Therapy Cuts Covid-19 Hospitalization By 70%",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "Antibody",
                    "Therapy",
                    "Cuts",
                    "Covid-19",
                    "Hospitalization",
                    "70%"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Eli Lilly’s Antibody Therapy Cuts Covid-19 Hospitalization By 70%",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-02-21",
            "original_text": "Eli Lilly, Regeneron's COVID-19 treatments may be weaker against South Africa variant-study",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "Regeneron",
                    "COVID-19",
                    "treatments",
                    "weaker",
                    "South Africa",
                    "variant",
                    "study"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Eli Lilly, Regeneron's COVID-19 treatments may be weaker against South Africa variant-study",
                "Correlation": 8,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]